ALC:NYSE
Alcon AG
$74.12
0.00%
(0.00) 1D
$74.46
arrow_upward
+0.46% (+0.34)todayPre-market
Closed: Nov 13, 4:00:05 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Mkt. cap
31.39B
Avg. vol.
2.14M
Volume
13.71K
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
Mkt. cap
31.39B
Avg. vol.
2.14M
Volume
13.71K
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
marketscreener.com
·
26 minutes ago
BofA Securities Adjusts Nasdaq Price Target to $135 From $133, Maintains Buy Rating
Barron's
·
1 hour ago
S&P 500 Futures Fall in Premarket Trading; TELUS Corp., Vaxcyte Lead
The Motley Fool
·
1 hour ago
If You Had Invested $10,000 in the Vanguard S&P 500 ETF (VOO) in 2016, Here's What You Would Have Today
Serrari Group
·
5 hours ago
Goldman Sachs Sees S&P 500 at 8,700 as AI Boom Slows
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorHealth Care
IndustryMedical device
Websitealcon.com